Oakman looks to raise £5.3m from shareholders

Oakman Group's CEO, Dermot King & Exec Chairman Peter Borg-Neal - med res

The discounted share placement will provide a buffer to protect the business from a further worsening of the trading environment

Already have an account?

red tick

You have reached your article limit

Register for limited access

Register for free

50% off your first 3 months

Subscribe now